Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Everion+ System

K-Number: K213863 · 2023-02-23

Decision Date2023-02-23
Product CodeMSX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Everion+ System is a medical device manufactured by Biofourmis Singapore Pte., Ltd.. It received FDA 510(k) clearance on 2023-02-23 under approval number K213863. The device is classified under product code MSX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Everion+ System?

Everion+ System is a medical device that received FDA 510(k) clearance on 2023-02-23. It is manufactured by Biofourmis Singapore Pte., Ltd.. The 510(k) number is K213863.

When was Everion+ System approved by the FDA?

Everion+ System received FDA 510(k) clearance on 2023-02-23, under approval number K213863.

What company makes Everion+ System?

Everion+ System is manufactured by Biofourmis Singapore Pte., Ltd..

What is the FDA product code for Everion+ System?

The FDA product code for Everion+ System is MSX.

Other Devices by Biofourmis Singapore Pte., Ltd.

Related Devices (Code: MSX)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.